Cyclophilins are prolyl isomerases with multitude of functions in different cellular processes and pathological conditions. Cyclophilin A (PpiA) of Mycobacterium tuberculosis is secreted during infection in intraphagosomal niche. However, our understanding about the evolutionary origin, secretory mechanism or the interactome of M. tuberculosis PpiA is limited. This study demonstrates through phylogenetic and structural analyses that PpiA has more proximity to human cyclophilins than the prokaryotic counterparts. We report a unique N-terminal sequence (MADCDSVTNSP) present in pathogenic mycobacterial PpiA and absent in non-pathogenic strains. This sequence stretch was shown to be essential for PpiA secretion. The overexpression of full-length PpiA from M. tuberculosis in non-pathogenic Mycobacterium smegmatis resulted in PpiA secretion while truncation of the N-terminal stretch obstructed the secretion. In addition, presence of an ESX pathway substrate motif in M. tuberculosis PpiA suggested possible involvement of Type VII secretion system. Site-directed mutagenesis of key residues in this motif in full-length PpiA also hindered the secretion in M. smegmatis. Bacterial two-hybrid screens with human lung cDNA library as target were utilized to identify interaction partners of PpiA from host repertoire, and a number of substrates with functional representation in iron storage, signal transduction and immune responses were detected. The extensive host interactome coupled with the sequence and structural similarity to human cyclophilins is strongly suggestive of PpiA being deployed by M. tuberculosis as an effector mimic against the host cyclophilins.
Citation: Bhaduri A, Misra R, Maji A, Bhetaria PJ, Mishra S, Arora G, et al. (2014) Mycobacterium tuberculosis Cyclophilin A Uses Novel Signal Sequence for Secretion and Mimics Eukaryotic Cyclophilins for Interaction with Host Protein Repertoire. PLoS ONE 9(2): e88090. https://doi.org/10.1371/journal.pone.0088090
Editor: Volker Briken, University of Maryland, United States of America
Received: June 22, 2013; Accepted: January 3, 2014; Published: February 4, 2014
Copyright: © 2014 Bhaduri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant BSC0104 from the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors declare that they have no conflict of interest.
Pathogenic microbiota, during evolution, have acquired strategic assets like pathogenicity islands, antigenic variation, quorum sensing ability, virulence factors and mimics to combat the eukaryotic host –. Mycobacterium tuberculosis, one of the oldest human pathogens, also possesses a complex machinery to subvert host defense mechanisms. Studies on M. tuberculosis virulence factors, specialized cell-wall lipids and novel secretory pathways have changed the earlier anthropocentric view of granuloma formation and mycobacterial transmission to a bacteriocentric interpretation –. This is also corroborated by reports on different clinical isolates of M. tuberculosis complex where modern lineages have been shown to be more aggressive and instrumental in rapid progression of tuberculosis . A large number of secreted proteins of mycobacteria, some secretory pathways have been identified in recent times and with role of few of these secretory proteins established during infection process; the attention has now refocused on secretome , , , .
Cyclophilins are one of the four structurally different groups of peptidyl-prolyl isomerases (the other families being FK506 binding proteins, parvulins and PP2A phosphatase activator), which modulate equilibration of cis or trans isomers of proline , . The cyclophilins belong to an ancient protein family ubiquitous throughout organismal hierarchy , . Unlike the eukaryotes, which encode multitude of cyclophilins, most prokaryotes possess a few cyclophilins , . The prokaryotic cyclophilins contain a single cyclophilin-like domain (CLD) unlike the large multi-domain eukaryotic counterparts and show a weaker cyclosporin A binding capacity than the eukaryotic cyclophilins , . The role of prolyl isomerases has been implicated in diverse vital processes which include, but are not restricted to, protein folding, chaperoning, RNA processing, signal transduction, stress responses and cell death , , . The functions of these regulators have also been established in various pathological conditions like cancer, Alzheimer's disease, atherosclerosis, diabetes, asthma and in various viral diseases including HIV , , .
M. tuberculosis has two cyclophilins, namely cyclophilin A (PpiA) and cyclophilin B (PpiB). The former has been shown to be present in culture filtrates in several studies ,  and is reported to be upregulated in intraphagosomal niche during infection . Although independent groups have partly characterized PpiA with respect to cyclosporin binding or structural moiety , , no thorough investigation has been made to understand the phylogeny, secretion mechanism and interactome of PpiA.
This study illustrates that M. tuberculosis PpiA is a unique cyclophilin with significant sequence and structural similarity to eukaryotic cyclophilins. Comparative sequence analysis of cyclophilins from pathogenic and non-pathogenic mycobacterial species revealed a stretch of N-terminal residues specific to pathogenic mycobacteria. The expression of full-length M. tuberculosis PpiA in the non-pathogenic Mycobacterium smegmatis resulted in the secretion of PpiA while the secretion of a truncated PpiA (lacking the proposed signal sequence) overexpressed in M. smegmatis was almost negligible. Moreover, site directed mutagenesis of a proposed ESX pathway motif (YXXXD/E) in the full-length M. tuberculosis PpiA also resulted in loss of secretion in M. smegmatis overexpression strain. This suggested a possible involvement of mycobacterial type VII secretion system in PpiA secretion. The bacterial two-hybrid studies using PpiA as bait and human lung cDNA as target revealed a number of interacting partners from human repertoire. The structural overlapping of PpiA with human cyclophilins along with the pathogen specific signal sequence and a wide-ranging host interactome is indicative of a possible mimicry.
Results and Discussion
In silico analysis of M. tuberculosis PpiA
The growing number of studies depicting the diverse functions of cyclophilins encouraged us to explore mycobacterial cyclophilins, especially PpiA. Multiple sequence alignments and consequent phylogenetic analyses of available mycobacterial cyclophilin protein sequences revealed that both PpiA and PpiB type cyclophilins have conserved sequence patterns and thus form two distinct clusters in mycobacteria (Figure 1A). Since M. tuberculosis PpiA was previously shown to bind with cyclosporin A , a characteristic unlike of prokaryotic cyclophilins, we next generated a phylogram containing all human cyclophilins, PpiA and several mycobacterial PpiB type cyclophilins. Interestingly, PpiA coaligned with human cyclophilins rather than the mycobacterial PpiB type cyclophilins (Figure 1B). We further aimed to position M. tuberculosis PpiA in the organismal hierarchy with a broader phylogenetic analysis. M. tuberculosis PpiA and PpiB were aligned with over 200 cyclophilin protein sequences from a wide range of eukaryotes and prokaryotes. In the resultant phylogram, M. tuberculosis PpiA was placed incongruently in a clade comprising of eukaryotic and actinobacterial representatives, separated from the prokaryotic clades (Figure 2). Interestingly, M. tuberculosis PpiB was also separated from other bacterial cyclophilins and formed a clade of actinobacterial-specific cyclophilins (Figure S1 in File S1). The positioning of M. tuberculosis PpiA and PpiB in separate clades than those of prokaryotic cyclophilins suggested that both the mycobacterial cyclophilins belong to an evolutionarily different group from the prokaryotic counterparts. Different outgroupings were then performed to construct separate phylograms for an unbiased analysis. Though PpiB was closer to some of the prokaryotic cyclophilins in few of these resultant trees, in none of these phylogenetic analyses PpiA could be placed with other prokaryotic counterparts (Figure S2 in File S1). The prokaryotic and actinobacterial clades identified in the present work were comparable to a previous in silico study on actinobacterial cyclophilins . The apparent differences in other clades could stem from the fact that all 17 human cyclophilins and cyclophilins from various representative organisms were included for a comprehensive analysis in the present work. The clustering of PpiA with actino-eukaryotic group was suggestive of a possible horizontal gene transfer event. Although inter-kingdom gene transfer is shown to be highly prevalent in mycobacteria , a direct role of horizontal gene transfer seemed uncertain since flanking region search for the source of M. tuberculosis ppiA did not show any match with the human counterparts. The other possibility of M. tuberculosis PpiA having eukaryotic resemblance could be due to structural and/or functional mimicry. The ‘Chimera’ program was used for structural alignment studies between M. tuberculosis PpiA and human cyclophilins PPWD1, PPIAL3 and PPIC as these were found to possess maximum sequence similarity (46–48%) to M. tuberculosis PpiA in the protein BLAST. These were also found to be the closest counterparts of M. tuberculosis PpiA in different phylogenetic trees constructed during this work. Human PPIA and Escherichia coli PpiA were also selected for overlapping analysis as representatives of eukaryotic and prokaryotic cyclophilins, respectively. M. tuberculosis PpiA showed almost complete overlapping with HPPWD1 and other human cyclophilins while a poor overlapping was revealed in structural alignment with E. coli PpiA (Figure 3A, B). When a multi-alignment file was created with the cyclophilin domain of PPWD1, PPIAL3, PPIC, PPIA and M. tuberculosis PpiA, the overlap was distinctly visible apart from loop insertion in the latter (Figure 3C). A multiple sequence alignment of protein sequence was then performed for PpiA with all human cyclophilins and this loop with a sequence ‘AQGTKDYSTQNASGGP’ was indeed found to be absent in human cyclophilins (Figure 3D). The loop region was also found to be of epitopic nature when immunoinformatics analysis of M. tuberculosis PpiA was executed (Figure 3E). This strong structural similarity of a mycobacterial secretory protein to a number of host cyclophilins suggests a possible role of PpiA being deployed as a mimic. Various effector mimic proteins have been characterized from different pathogens like Salmonella sp. and Shigella sp. ,  and we postulate that M. tuberculosis has also engineered a protein (human counterparts of which are regulators of cellular functions) to sabotage the host defense.
Fig. 1A: The phylogram of mycobacterial cyclophilins revealed two distinct clades of PpiA and PpiB. Fig. 1B: M. tuberculosis PpiA (MTBPPIA) aligned with human cyclophilins (initials ‘HPP’) instead of clustering with other mycobacterial cyclophilins (initial ‘M’). In both Fig. 1A and B, M. tuberculosis PpiA and PpiB are labeled red and green, respectively.
A circular phylogram representation of the cyclophilin sequences collected from various taxa. M. tuberculosis PpiA is grouped with eukaryotic and actinobacterial counterparts quite distinct from the prokaryotic clades of cyclophilins. The colored labels are used as follows: human cyclophilins – green, M. tuberculosis and Mycobacterium leprae PpiA – red, M. tuberculosis and M. leprae PpiB – brown, E. coli cyclophilins – pink and selected gut microbial cyclophilin – dark blue.
Fig. 3A: Structural overlapping of M. tuberculosis PpiA (green) with human PPWD1 (yellow) demonstrated almost complete overlap, (inset showing the loop region). Fig. 3B: Comparative analysis of structural overlapping between M. tuberculosis PpiA (green) with human PPWD1 (yellow) as well as with E. coli PpiA (red), respectively, revealed a poor overlap with the prokaryotic cyclophilin. Fig. 3C: Structural overlapping of M. tuberculosis PpiA (green) and four human cyclophilins (HPPWD1, HPPIAL3, HPPIC, HPPIA) by Chimera program showed almost complete overlap apart from a region of difference (in form of a loop) in M. tuberculosis PpiA. Fig. 3D: Multiple sequence alignment of the human cyclophilins and M. tuberculosis PpiA identified the region of difference ‘AQGTKDYSTQNASGGP’ (inset, black-bordered box). Fig. 3E: Immunoinformatics analysis using ABCpred software identified putative epitopic regions in M. tuberculosis PpiA.
A novel signal sequence and secretion of M. tuberculosis PpiA
The possibility that M. tuberculosis PpiA acts as a virulence factor prompted us to carry out a detailed analysis of the mycobacterial PpiA sequences. A phylogram of available mycobacterial PpiA type cyclophilins separated the pathogenic and non-pathogenic mycobacteria into different clades (Figure 4A). The sequence alignment revealed a stretch of N-terminal amino acids present only in pathogenic mycobacteria (Figure 4B). The first twenty amino acids from pathogenic mycobacteria and the corresponding stretch from non-pathogenic mycobacteria were selected for creation of respective sequence logos (Figure 4C). This alignment showed that approximately 12 amino acids (MADCDSVTNSPL) were conserved among the pathogenic mycobacteria with some variations in D3, C4, S6 and L12 residues. In non-pathogenic mycobacteria, this sequence was either absent or replaced by a longer stretch of entirely different amino acids. This N-terminal stretch of amino acids in the cyclophilins of pathogenic mycobacteria appeared like a novel signal sequence. To the best of our knowledge, there is no report of secretion of any non-pathogenic mycobacterial cyclophilin. It was thus presumed that overexpression of PpiA from a pathogenic Mycobacterium in a non-pathogenic Mycobacterium could result in the secretion of the protein provided the pathway for secretion exists in the bacterium. The overexpression of M. tuberculosis PpiA in M. smegmatis resulted in secretion of the protein. To prove that this signal sequence was indispensible for proper secretion, a truncated version (lacking the conserved 12 amino acids) of PpiA was created and overexpressed in M. smegmatis. The culture filtrate comparison between the strains showed that the full-length form of PpiA was getting secreted while the truncated PpiA was not secreted or secreted below detectable levels (Figure 5A–B). This confirmed that the N-terminal stretch is necessary for secretion and could represent a novel signal sequence. To identify the localization pattern, immunoelectron microscopy was performed with full-length PpiA overexpression strain. The secretion does not seem to be restricted to any specific area, though in longitudinal sections, some patches of secreted proteins were observed near the middle and the terminal portions of the bacteria (Figure 5C).
Fig. 4A: A phylogram of mycobacterial PpiA type cyclophilins revealed the coalescing of pathogenic mycobacteria (red) into a clade, different than that of non-pathogenic mycobacteria (black). Fig. 4B: Sequence alignment of the N-terminal stretch revealed that the proposed signal sequence present in pathogenic mycobacterial PpiA was either missing or mismatched in non-pathogenic species. Fig. 4C: Sequence logo analysis of the N-terminal stretch of the mycobacterial PpiA type cyclophilins.
Immunoblotting was performed to show differential secretion pattern of overexpressed full-length, truncated and YD-ESX mutant forms of M. tuberculosis PpiA in the culture filtrates of M. smegmatis. Fig. 5A: Presence of overexpressed full-length, truncated and YD ESX mutant PpiA in the whole cell lysates (CL) of M. smegmatis (left upper panel). Secretion of overexpressed full-length PpiA is evident in M. smegmatis culture filtrate (CF) while the truncated PpiA without the proposed signal sequence and YD ESX mutant PpiA, though expressed, is not secreted (left lower panel). Expression of Ag85 homolog in all culture filtrates as a control for secretion (right upper panel) and expression of GroEl1 as a cell lysis control and (right lower panel). 12% SDS-PAGE was used in all these blots. Fig. 5B: Truncated PpiA and YD-ESX mutant PpiA showed very little amount of secretion even in two-fold culture filtrate concentrate with respect to the full-length PpiA culture filtrate. 16% SDS-PAGE was overrun to distinguish the size difference in these blots. Cell lysate (CL) fractions with two-fold concentrated amount of truncated and YD ESX mutant PpiA, top panel; Equal concentration of all culture filtrates, middle panel; and Culture filtrate fractions with two fold concentrate of truncated and YD ESX mutant PpiA, bottom panel. Fig. 5C: Immunoelectron micrograph showing localization of secreted full-length PpiA overexpressed in M. smegmatis in comparison with pVV16 vector control in M. smegmatis. Arrows indicate the position of PpiA. T.S: Transverse section, L.S: Longitudinal section.
To identify any components of the secretory pathway involved in PpiA secretion, affinity pull-down experiments were performed with mycobacterial lysates and purified His6-tagged M. tuberculosis PpiA. We did not find any substrates in the pull down assays with M. tuberculosis and M. smegmatis whole cell lysates from mycobacterial secretory apparatus. However, these pull-down assays and subsequent mass-spectrometric analysis revealed chaperonin GroEL and elongation factor Tu as interacting partners (Table 1). These interactions confirmed earlier reports depicting interaction between prolyl isomerases and chaperones . The possibility of PpiA secretion through the twin-arginine transport system or general secretory pathways was ruled out since PpiA sequence did not possess the characteristic features of the substrates of these pathways , . Nonetheless, a motif ‘Y-XXX-D/E’ responsible for secretion of mycobacterial proteins through ESX system has been identified in a recent study  and the PpiA sequence contains a similar motif (‘YKFADE’). To test this hypothesis, we carried out site directed mutagenesis of key residues (Y/A and D/A) in this ESX motif in full-length and truncated PpiA constructs. Upon overexpression, the secretion in the mutant strains was negligible (Figure 5A–B). Although a detailed study is required to come to a conclusion regarding PpiA secretion, our results put forward a possibility that M. tuberculosis is using type VII secretion system along with the proposed N-terminal signal sequence to secrete PpiA in the host milieu.
M. tuberculosis PpiA-host interactome
The proposed eukaryotic nature of cyclophilin indicated that once secreted, cyclophilin has the ability to interact with host targets. We performed a bacterial two-hybrid screening (BacterioMatch®) to search for the interaction partners of PpiA. The human lung cDNA library was chosen to accommodate a broad range of genes from different cell clusters in the primary micro-niche of tubercle bacilli (Figure S3 in File S1). The two-hybrid experiments identified a number of PpiA substrates with a wide spectrum of functional diversity (Table 2). These substrates are known to function in iron regulation, immune response, signal transduction, translational apparatus, apoptotic machinery and several other cellular mechanisms. Cyclophilins are known to be involved in intra/extra cellular signaling and so it was not surprising to have some substrates from signal transduction machinery and translational apparatus in PpiA interactome (PTK2, TMEM173, EEF1A1). M. tuberculosis PpiA expression is reduced in limited iron conditions  and the identification of substrates (ATP6V0E1, FTH1, LCN2) involved in iron uptake, binding and transportation indicates a possible function of PpiA in iron regulation. Some of the interacting partners identified in two-hybrid studies are implicated in receptor signaling and immune response (CD74, IFITM1, LY6E) and suggest a strategy of immune subversion by M. tuberculosis through PpiA. Interestingly, various database searches revealed that most of the PpiA substrates were involved in different human disease pathologies including tuberculosis (Table S1 in File S1). The two-hybrid study also detected several immunoglobulin heavy chain variable regions interacting with PpiA. The finding of the epitopic loop in the structural analysis suggested that the peripheral positioning may assist in the interaction of PpiA with the substrates (Figure 3). Together, the results obtained from the library screening and structural analysis suggested PpiA to be a potential antigen for the human host despite the fact that it closely resembled many of the human cyclophilins. This hypothesis was also supported by a recent study depicting PpiA as an immunodominant antigen . Affinity pull-down experiments were also performed with human macrophage and lung epithelial cell lysates to check whether the ex vivo interactions could be detected at the in vitro level and a few substrates like ferritin, elongation factor, surfactant protein and protein tyrosine kinase were continual with the library screening (Table 3). The identification of the substrate microtubule associated protein tau (MAPT) from the pull-down assay demonstrated the ability of PpiA to act as a molecular mimic as MAPT was previously shown to be a target of prolyl isomerase Pin1 and implicated directly in protection against Alzheimer's disease . We have further validated the interaction of PpiA-EfTu in native PAGE and PpiA-Tau in the pull down experiment using Anti-Tau antibody (Figure S4 in File S1). However, cyclophilin being an extremely interactive protein, further research is required to assess which substrates are encountered and acted upon by M. tuberculosis PpiA during the process of infection. The PpiA-host protein-protein interaction landscape, reported in our study, revealed many PpiA substrates which are important either in signaling network or are specific to some selected pathways. Some of these substrates like elongation factor, tyrosine kinase are involved in signal transduction and thus could be termed the ‘hub’ of protein network while proteins like ferritin, surfactant proteins, vacuolar ATPase could represent the ‘bottlenecks’ which are specific and occupy central nodes in the protein-protein interaction networks . A STRING interaction network of the identified substrates revealed interconnectivity through protein-protein interaction profile suggestive of mycobacterial strategy to target specific pathways as well as signaling ‘hub’ (Figure S5 in File S1). In the recent past, cyclophilins have been shown to operate as virulence factors in some pathogenic bacteria and parasitic protozoa ,  and our study also indicates a similar function of M. tuberculosis PpiA.
This study demonstrates that M. tuberculosis PpiA is a eukaryotic-type cyclophilin possibly deployed as a mimic to the human cyclophilins (Figure 6, schematic representation). Our work illustrates the unique positioning of mycobacterial cyclophilins in organismal hierarchy and provides new insights on cyclophilin phylogeny. We have identified a unique signal sequence that is present in pathogenic mycobacterial PpiA and absent in non-pathogenic mycobacterial PpiA. The presence of the signal sequence only in pathogenic mycobacterial PpiA pointed towards the virulence specific function of PpiA. We showed that deleting the signal sequence obstructs the secretion of the protein while the full-length protein when overexpressed in a non-pathogenic Mycobacterium, gets secreted. Furthermore, M. tuberculosis PpiA also contained a motif sequence similar to those observed in type VII secretion system substrates . Overexpression of mutants of this ESX motif also resulted in loss of secretion in full-length PpiA in M. smegmatis, indicating a probable function of ESX pathways in PpiA secretion. Concurrent with the phylogenetic and structural analysis which showed that PpiA is closer to human cyclophilins, we have also identified a significant number of interaction partners of PpiA from the human host, many of which are known to be involved in iron regulation, immune-defense mechanism and signal transduction machinery. This report, therefore, is suggestive of a delicate balance in the host-pathogen interaction wherein M. tuberculosis could use the eukaryotic-type cyclophilin to interact and modify certain host proteins while the host immune machinery could try to target the epitopic loop region in PpiA to differentiate this ‘foreign’ cyclophilin from its large repository of ‘self’ cyclophilins.
Fig. 6A: Pathogenic mycobacterial PpiA contains the N-terminal stretch which acts as a signal sequence and aids in PpiA secretion while in non-pathogenic mycobacteria, the truncated PpiA is not secreted or secreted in negligible amount. PpiA might be utilizing the newly identified ESX substrate motif for secretion through mycobacterial type VII secretion system. The phylogenetic and structural similarity of M. tuberculosis PpiA to human cyclophilins enables the former to interact with substrates from the host repertoire some of which otherwise could be targeted by the human cyclophilins. The mycobacterial cells are depicted as rectangular shaped rods and the human cell is represented in circular shape. The M. tuberculosis PpiA and human cyclophilins are shown in blue circle and named PpiA and Hcyp, respectively. Various other small shapes have been used to represent the protein repertoire within host cell. Fig. 6B: The PpiA amino acid sequence reveals interesting motifs.
Materials and Methods
In silico analysis of cyclophilins
The cyclophilins sequences were retrieved in the FASTA format from NCBI Protein Database (http://www.ncbi.nlm.nih.gov/protein) and by using NCBI protein BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins). Mycobacterium tuberculosis PpiA, PpiB and Homo sapiens cyclophilins were used as query to retrieve cyclophilin sequences from Mus musculus, Gallus gallus, Drosophila melanogaster, Danio rerio, Leishmania major, Caenorhabditis elegans, Arapdiopsis thaliana, Saccharomyces cerevisiae, Aspergillus niger, Chlamydomonas reinhardtii, Oscillatoria sp., Bacteroides thetaiotaomicron, Eubacterium rectale, Fusobacterium varium, Peptostreptococcus anaerobius, Streptococcus thermophilus, Bifidobacterium bifidum, Lactobacillus acidophilus, Ruminococcus lactaris, E. coli K-12, Bacillus anthracis, Campylobacter jejuni, Streptococcus pyogenes, Staphylococcus aureus, Shigella dysenteriae, Enterococcus faecalis, Yersinia pestis, Yersinia enterocolitica, Vibrio cholerae, Helicobacter pylori, Clostridium botulinum, Salmonella enterica, Pseudomonas aeruginosa, Listeria monocytogenes and available mycobacterial species. Mycobacteriophages were also searched for the presence of cyclophilins, if any, but no homologues were found. Over 280 sequences were used in separate phylogenetic analyses in the present study. All protein sequence accession numbers used in this study have been provided as dataset in File S2 (Dataset). Domain analysis was also carried out to confirm the presence of cyclophilin domain (CLD) in the retrieved sequences by subjecting each sequence to NCBI Conserved Domain Search (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). Full-length or selective motif sequences were included for visualizing the phylogenetic tree. Multiple sequence alignments were carried out using CLUSTAL X (2.0.12) . The resulting data were saved as CLUSTAL and PHYLIP format files and alignments were written as postscript files, when needed. The phylogenetic analyses were performed in PHYLIP (ver. 3.69) programs SEQBOOT, PROTDIST, NEIGHBOR, and CONSENSE in the order as described previously , . The Jones-Taylor-Thomton amino acid substitution matrix was performed and input order of sequences for phylogenetic analysis was randomized. Phylogenetic tree CONSENSE files obtained from PHYLIP were scrutinized with TREEVIEW (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html) and MEGA (5.0) .
ABCpred prediction server was used for immunoinformatics analysis (http://www.imtech.res.in/raghava/abcpred/) to predict B cell epitopes. Structures of the selected sequences were obtained from PDB database, as described previously ,  and sequence alignments were done in CLUSTAL X. Individual or overlapped cyclophilin 3-D structures were viewed in Chimera (http://www.cgl.ucsf.edu/chimera/) . The PDB ids used for structural analyses are as follows: 1W74 (M. tuberculosis PpiA), 1LOP (E. coli PpiA), 2CPL (Human PPIA), 2A2N (Human PPWD1), 2OK3 (Human PPIL3), 2ESL (PPIC) , . Specific regions of interest are shown in Figure 3.
Cloning of ppiA in mycobacterial shuttle vector
The gene fragment coding for ppiA (rv0009) was PCR amplified from M. tuberculosis H37Rv genomic DNA using gene specific forward (5′-GCCCGCCCGGGCCATATGGCAGACTGTGATTCC-3′) and reverse primer (5′-GCCGACGTAGCTTCAAGCTTGGAGATGGTGATCGACTCG-3′) and cloned in pVV16 shuttle vector using NdeI and HindIII restriction enzymes. For the truncated version of ppiA, a new primer replaced the forward primer with the sequence (5′-CCGTGACTAACAGCCATATGGCGACCGCTACCGCC-3′). All clones were confirmed by restriction digestion and sequencing.
Mycobacterial growth conditions and preparation of cell lysate and culture filtrate
M. tuberculosis H37Rv and M. smegmatis MC2 155 were grown at 37°C, in Middlebrook 7H9 broth and Middlebrook 7H10 agar supplemented with 0.5% glycerol, 10% Albumin Dextrose Catalase (ADC) and 0.05% Tween 80 and kanamycin, as required. For preparing the culture filtrate, M. smegmatis cultures were grown in 7H9 or Sauton's media in static or mild shaking (50 rpm) condition and after centrifugation the supernatant was filtered through a 0.2-µm filter. The filtrate was concentrated either by passing through Amicon® ultra centrifugal filters or by ammonium sulphate precipitation. Whole cell extracts of M. tuberculosis and M. smegmatis were prepared as described previously . In brief, cell pellet was harvested by spinning the bacterial culture at 5000 rpm for 10 min and resuspended in phosphate buffered saline (PBS) containing protease inhibitor cocktail (Roche). Zirconium beads were added and bead-beating was performed. The cell debris was sedimented by centrifugation at 13,000 rpm for 30 min and the supernatant was collected and processed as required.
Generation of antibody for PpiA and immunoblotting
The anti-PpiA antibody was obtained from M/S Indo Biotek, India. In brief, the peptide (‘AQGTKDYSTQNASGGP’-Cys) was selected for conjugation with KLH and antibody raised in rabbit as per standard protocol . Standard protocols of immunoblotting were followed as described before , . In brief, concentrated culture filtrate or cell lysate was separated on SDS-PAGE and transferred onto nitrocellulose membrane. After blocking, the blots were incubated with anti-PpiA/anti-His6 antibody for 1–2 hr (anti-PpiA dilutions of 1∶10000 in cell lysates and 1∶5000 in culture filtrate; anti-His6 dilutions: 1∶15000 in cell lysates and 1∶5000 in culture filtrate). This was followed by washes with PBST and then secondary antibody incubation was performed for 1 hr at room temperature with HRP-conjugated anti-rabbit IgG antibody (Bangalore Genei) at 1∶10,000 dilutions. After three washes, the blots were developed using SuperSignalR West Pico/Femto Chemiluminescent Substrate kit (Pierce, Rockford). Similar results were obtained with anti-PpiA and anti-His6 antibodies.
Site Directed Mutagenesis.
The YD ESX mutants (YFKAD to AFKAA) were generated in full-length and truncated PpiA constructs using the QuikChange XL Site directed Mutagenesis kit (Stratagene) as previously described . The following primers were used for generation of mutant constructs: F.P (5′-CGCGGCGGACCCGGCGCCAAGTTCGCCGCCGAGTTCCACCCCG-3′) and R.P (5′-CGGGGTGGAACTCGGCGGCGAACTTGGCGCCGGGTCCGCCGCG-3′).
Immunoelectron microscopy was done as described previously . In brief, the log-phase cultures of M. smegmatis were harvested, washed with phosphate buffer (pH 7.2) and fixed in 100 mM sodium cacodylate buffer (pH 7.4) containing 4% paraformaldehyde and 2.5% glutaraldehyde for 24 h. The pellet was osmicated with 0.5% OsO4–0.8% K3Fe(CN)6 followed by 1% tannic acid and stained overnight in 1% uranyl acetate. The cells were gradually dehydrated and embedded in LR White resin and sections were cut using an ultra microtome. Sections on grids were first blocked for 0.5–1 hour followed by washing and overnight incubation at 4°C with rabbit anti-PpiA antibody diluted to 1∶200. The grids were again washed the next day and the bound antibodies were localized by incubation of the sections with secondary gold-conjugated antibody. Grids were washed, stained with 2% aqueous uranyl acetate and observed in a Philips Morgagni 268 microscope.
BacterioMatch® two-hybrid screen.
BacterioMatch® two-hybrid system vector kit and corresponding E. coli competent cells (BacterioMatch® two-hybrid system reporter strain were originally purchased from Stratagene, presently Agilent Technologies, USA) were obtained as a kind gift from Dr. A. Ranganathan (ICGEB, New Delhi) . The BacterioMatch® kit was supplied with bacterial two-hybrid system plasmids, pBT and pTRG, and control plasmids pBT-LGF2 and pTRG-Gal11p. BacterioMatch® two-hybrid system was used as described previously . In brief, full-length ppiA was PCR amplified from M. tuberculosis H37Rv genomic DNA using forward (5′-CCGCCCGGAATTCAATGGCAGACTGTGATTCC-3′) and reverse (5′-TGTATTCGAGCCTCGAGCCGACGTAGCTTC-3′) primers containing EcoRI and XhoI restriction sites as bait in pBT plasmid. Human lung cDNA library available in pTRG plasmid was used as target. The reporter strain E. coli XL1 Blue competent cells were co-transformed with equal amounts (250 ng each) of ppiApBT and human lung-cDNApTRG library constructs. The interaction of PpiA expressed from pBT vector to a particular cDNA fragment expressed from pTRG vector results in LacZ expression and growth of blue colonies when plated on X-gal indicator plates containing kanamycin (25 µg/ml), chloramphenicol (30 µg/ml), tetracycline (12.5 µg/ml), X-Gal (80 µg/ml), IPTG (25 µM), and X-Gal inhibitor (200 µM). While pBT and pTRG plasmids alone served as negative controls, pBT-LGF2 and pTRG-Gal11p were used as the positive controls for color scheme for all ex vivo interaction studies, as described previously. To avoid false positives, colony PCR was performed for the selected colonies using both ppiA specific and vector specific primers to search for the ppiA gene and probable cDNA fraction. The PCR confirmed colonies were separated by repeated transformation to divide the plasmids according to their antibiotic resistance and again re-co-transformed to check the presence of coloration in the X-gal indicator plates. The positive cDNA fragments after repeated separation and co-transformation were sequenced and the genes were identified through nucleotide BLAST against human genomic sequences (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn).
Purification of His6-tagged PpiA protein and pull-down experiments.
Recombinant His6-tagged ppiA was cloned in pProEx-HTc expression vector using (5′-TGGGGGCCCGCCGGATCCTAATGGCAGACTG-3′) forward and (5′-GCCGACGTAGCCTCGAGTCAGGAGATGGTGATCG-3′) reverse primers. Proteins were expressed and purified as described earlier . The purified proteins were analyzed by SDS-PAGE and concentrations were estimated by Bradford assay (Bio-Rad). Affinity pull-down assays were performed with Ni-NTA resin for the His6-tagged protein. The resin was washed with binding buffer (300 mM KCl, 30 mM Imidazole, 20 mM Tris (pH-7.4), 1% NP-40, 2 mM EDTA, 2 mM PMSF/PI) and purified His6-tagged PpiA protein was slowly added to the resin and allowed to bind for 1 h with Ni-NTA resin at 4°C with gentle shaking. Mycobacterial/mammalian cell lysates were added to the mix and kept for 30 min–1 h at 4°C with gentle shaking. The unbound proteins were collected separately by centrifugation at 3000 rpm for 3 min. The remaining resin was washed thrice with binding buffer. The elution was performed using buffer containing 300 mM KCl, 200 mM Imidazole, 20 mM Tris pH-7.4, 1% NP40, 2 mM PMSF/PI, 2 mM EDTA. The eluted fractions were separated on 12% SDS-PAGE gel and stained with Coomassie blue. The interacting protein bands observed on the gel were cut and processed for MALDI analysis as described earlier (Table S2 in File S1, File S2) .
Figures S1–S5 and Table S1 and S2. Figure S1. Clade details of M. tuberculosis and E. coli PpiA and PpiB. The phylogram revealed unique positioning of M. tuberculosis PpiA in an actino-eukaryotic clade. The M. tuberculosis PpiB was also similarly placed in an actinobacterial clade while both E. coli PpiA and PpiB were grouped within a distinct prokaryotic cyclophilin clade. Figure S2. Phylogeny of M. tuberculosis PpiA. Several outgroupings was performed in the corresponding CONSENSE tree file of Fig. 2. However, in no resultant tree M. tuberculosis PpiA was grouped with prokaryotic clusters. Even in the phylogram shown above, M. tuberculosis PpiA is placed in an entirely different clade as that of the prokaryotic cyclophilins. (Colors used as in Fig. 2). Figure S3. Schematic diagram of two hybrid library screen. Fig. S3A: The process involved in BacterioMatch two hybrid library screening. Fig. S3B: The details in the screening of PpiA interaction with inhibitor and positive controls. Figure S4. Interaction of PpiA with M. tuberculosis Ef-Tu (Tuf) and human Tau (MAPT) protein. Fig. S4A. Individual lanes showing purified Ef-Tu and PpiA (two right panels) and interaction of Ef-Tu and ppiA showing bands in the top regions (two extreme left panels). Fig. S4B. Blot developed with Anti-Tau antibody (Abcam) showing presence of Tau protein in macrophage (ThP1) cell lysate and PpiA pull-down interaction. Figure S5. STRING interaction network of substrates identified in two-hybrid screening. The display shows the interconnectivity of most of the substrates of M. tuberculosis PpiA from the host protein repertoire. Table S1. The host substrates of M. tuberculosis PpiA has been implicated in various pathological conditions and the expression level of PpiA interacting partners has been shown to be altered in different diseases including tuberculosis. (Source: literature search, databases like Gene expression Atlas, GeneCards, RefGene, OMIM, BioGRID, STRING). Table S2. Cell lines in which lysates pull-down interaction between purified M. tuberculosis PpiA and human substrates were identified.
We thank Dr. Anand Ranganathan for kindly providing us the BacterioMatch® system. We would like to thank Prof. P.U. Sarma, Dr. V.K. Nandicoori and Dr. V.C. Kalia for suggestions in improving the manuscript and Dr. T.K. Das for providing electron microscopy facility, AIIMS. We also thank Anshika Singhal, Arjun Ardey and Shalini Sharma for scientific discussions and technical support.
Conceived and designed the experiments: AB YS JSV. Performed the experiments: AB RM PB SM AM GA LKS. Analyzed the data: AB RM YS. Contributed reagents/materials/analysis tools: AB RM PB N. Dubey. Wrote the paper: AB RM N. Dhasmana YS JSV.
- 1. Gal-Mor O, Finlay BB (2006) Pathogenicity islands: a molecular toolbox for bacterial virulence. Cell Microbiol 8: 1707–1719.
- 2. Gama JA, Abby SS, Vieira-Silva S, Dionisio F, Rocha EP (2012) Immune subversion and quorum-sensing shape the variation in infectious dose among bacterial pathogens. PLoS Pathog 8: e1002503.
- 3. Orchard RC, Alto NM (2012) Mimicking GEFs: a common theme for bacterial pathogens. Cell Microbiol 14: 10–18.
- 4. Brennan PJ (2003) Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 83: 91–97.
- 5. Jayachandran R, Scherr N, Pieters J (2012) Elimination of intracellularly residing Mycobacterium tuberculosis through targeting of host and bacterial signaling mechanisms. Expert Rev Anti Infect Ther 10: 1007–1022.
- 6. Ramakrishnan L (2012) Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 12: 352–366.
- 7. Russell DG (2007) Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5: 39–47.
- 8. Portevin D, Gagneux S, Comas I, Young D (2011) Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog 7: e1001307.
- 9. Ligon LS, Hayden JD, Braunstein M (2012) The ins and outs of Mycobacterium tuberculosis protein export. Tuberculosis (Edinb) 92: 121–132.
- 10. Malen H, Berven FS, Fladmark KE, Wiker HG (2007) Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 7: 1702–1718.
- 11. Galat A (2003) Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity--targets--functions. Curr Top Med Chem 3: 1315–1347.
- 12. Lu KP, Finn G, Lee TH, Nicholson LK (2007) Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol 3: 619–629.
- 13. Davis TL, Walker JR, Campagna-Slater V, Finerty PJ, Paramanathan R, et al. (2010) Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biol 8: e1000439.
- 14. Wang P, Heitman J (2005) The cyclophilins. Genome Biol 6: 226.
- 15. Bang H, Pecht A, Raddatz G, Scior T, Solbach W, et al. (2000) Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium. Eur J Biochem 267: 3270–3280.
- 16. Krücken J, Greif G, von Samson-Himmelstjerna G (2009) In silico analysis of the cyclophilin repertoire of apicomplexan parasites. Parasit Vectors 2: 27.
- 17. Manteca A, Pelaez AI, Zardoya R, Sanchez J (2006) Actinobacteria cyclophilins: phylogenetic relationships and description of new class- and order-specific paralogues. J Mol Evol 63: 719–732.
- 18. Lee J, Kim SS (2010) Current implications of cyclophilins in human cancers. J Exp Clin Cancer Res 29: 97.
- 19. Takahashi K, Uchida C, Shin RW, Shimazaki K, Uchida T (2008) Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. Cell Mol Life Sci 65: 359–375.
- 20. Weldingh K, Rosenkrands I, Jacobsen S, Rasmussen PB, Elhay MJ, et al. (1998) Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun 66: 3492–3500.
- 21. Mattow J, Siejak F, Hagens K, Becher D, Albrecht D, et al. (2006) Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 6: 2485–2494.
- 22. Mitra D, Mukherjee S, Das AK (2006) Cyclosporin A binding to Mycobacterium tuberculosis peptidyl-prolyl cis-trans isomerase A--investigation by CD, FTIR and fluorescence spectroscopy. FEBS Lett 580: 6846–6860.
- 23. Henriksson LM, Johansson P, Unge T, Mowbray SL (2004) X-ray structure of peptidyl-prolyl cis-trans isomerase A from Mycobacterium tuberculosis. Eur J Biochem 271: 4107–4113.
- 24. Wolf YI, Kondrashov AS, Koonin EV (2000) Interkingdom gene fusions. Genome Biol 1: research0013.1–0013.15.
- 25. Friebel A, Ilchmann H, Aepfelbacher M, Ehrbar K, Machleidt W, et al. (2001) SopE and SopE2 from Salmonella typhimurium activate different sets of RhoGTPases of the host cell. J Biol Chem 276: 34035–34040.
- 26. Daleke MH, Ummels R, Bawono P, Heringa J, Vandenbroucke-Grauls CM, et al. (2012) General secretion signal for the mycobacterial type VII secretion pathway. Proc Natl Acad Sci U S A 109: 11342–11347.
- 27. Wong DK, Lee BY, Horwitz MA, Gibson BW (1999) Identification of fur, aconitase, and other proteins expressed by Mycobacterium tuberculosis under conditions of low and high concentrations of iron by combined two-dimensional gel electrophoresis and mass spectrometry. Infect Immun 67: 327–336.
- 28. Deenadayalan A, Sundaramurthi JC, Raja A (2010) Immunological and proteomic analysis of preparative isoelectric focusing separated culture filtrate antigens of Mycobacterium tuberculosis. Exp Mol Pathol 88: 156–162.
- 29. Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399: 784–788.
- 30. Dyer MD, Murali TM, Sobral BW (2008) The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog 4: e32.
- 31. Reffuveille F, Connil N, Sanguinetti M, Posteraro B, Chevalier S, et al. (2012) Involvement of peptidylprolyl cis/trans isomerases in Enterococcus faecalis virulence. Infect Immun 80: 1728–1735.
- 32. Kulkarni MM, Karafova A, Kamysz W, Schenkman S, Pelle R, et al. (2013) Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity. J Biol Chem 288: 8772–8784.
- 33. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
- 34. Felsenstein J (1989) PHYLIP - Phylogeny Inference Package (Version 3.2). Cladistics 5: 164–166.
- 35. Narayan A, Sachdeva P, Sharma K, Saini AK, Tyagi AK, et al. (2007) Serine threonine protein kinases of mycobacterial genus: phylogeny to function. Physiol Genomics 29: 66–75.
- 36. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731–2739.
- 37. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25: 1605–1612.
- 38. Arora G, Sajid A, Gupta M, Bhaduri A, Kumar P, et al. (2010) Understanding the role of PknJ in Mycobacterium tuberculosis: biochemical characterization and identification of novel substrate pyruvate kinase A. PLoS One 5: e10772.
- 39. Gupta M, Sajid A, Arora G, Tandon V, Singh Y (2009) Forkhead-associated domain-containing protein Rv0019c and polyketide-associated protein PapA5, from substrates of serine/threonine protein kinase PknB to interacting proteins of Mycobacterium tuberculosis. J Biol Chem 284: 34723–34734.
- 40. Deol P, Vohra R, Saini AK, Singh A, Chandra H, et al. (2005) Role of Mycobacterium tuberculosis Ser/Thr kinase PknF: implications in glucose transport and cell division. J Bacteriol 187: 3415–3420.
- 41. Kumar K, Tharad M, Ganapathy S, Ram G, Narayan A, et al. (2009) Phenylalanine-rich peptides potently bind ESAT6, a virulence determinant of Mycobacterium tuberculosis, and concurrently affect the pathogen's growth. PLoS One 4: e7615.